Cite
HARVARD Citation
Ono, A. et al. (2020). Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib. Therapeutic advances in medical oncology. p. . [Online].